Boothbay Fund Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,500
Closed -$2.69M 2165
2025
Q4
$2.69M Buy
+40,500
New +$2.62M 0.04% 479

Other funds holding DXCM

Boothbay Fund Management's DXCM Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in DexCom (DXCM) in Q1 2026: 4,486 shares worth $282K. The stake represents ﹤0.01% of the portfolio and ranks #1633 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in DXCM as recently as Q3 2025.

Boothbay Fund Management first reported a position in DXCM in Q4 2016 and has held it in 13 quarters since. The position peaked at $5.94M in Q3 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Boothbay Fund Management held 4,486 shares of DexCom worth $282K as of Q1 2026.
  • DexCom was a new Boothbay Fund Management position in Q1 2026.
  • DexCom made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1633 holding.
  • Boothbay Fund Management first reported a position in DexCom in Q4 2016 and has held it in 13 quarters since.
  • Boothbay Fund Management's DexCom position peaked at $5.94M in Q3 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.